Lexicon Pharmaceuticals, Inc. (LXRX)
1.52
-0.13
(-7.88%)
USD |
NASDAQ |
Oct 16, 16:00
1.55
+0.03
(+1.97%)
After-Hours: 20:00
Lexicon Pharmaceuticals Free Cash Flow (Quarterly) : -9.192M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.192M |
| March 31, 2026 | -14.73M |
| December 31, 2025 | -17.23M |
| September 30, 2025 | -23.83M |
| June 30, 2025 | 16.99M |
| March 31, 2025 | -43.78M |
| December 31, 2024 | -23.27M |
| September 30, 2024 | -53.93M |
| June 30, 2024 | -48.79M |
| March 31, 2024 | -55.13M |
| December 31, 2023 | -50.55M |
| September 30, 2023 | -41.70M |
| June 30, 2023 | -38.26M |
| March 31, 2023 | -31.86M |
| December 31, 2022 | -22.82M |
| September 30, 2022 | -19.44M |
| June 30, 2022 | -24.42M |
| March 31, 2022 | -23.50M |
| December 31, 2021 | -22.85M |
| September 30, 2021 | -17.36M |
| June 30, 2021 | -22.83M |
| March 31, 2021 | -25.20M |
| December 31, 2020 | -34.29M |
| September 30, 2020 | -40.41M |
| June 30, 2020 | -46.30M |
| Date | Value |
|---|---|
| March 31, 2020 | -22.05M |
| December 31, 2019 | -24.37M |
| September 30, 2019 | 190.70M |
| June 30, 2019 | -26.90M |
| March 31, 2019 | -25.69M |
| December 31, 2018 | -27.16M |
| September 30, 2018 | -22.18M |
| June 30, 2018 | -52.54M |
| March 31, 2018 | -46.82M |
| December 31, 2017 | -33.72M |
| September 30, 2017 | -34.02M |
| June 30, 2017 | -32.30M |
| March 31, 2017 | -85.59M |
| December 31, 2016 | -48.94M |
| September 30, 2016 | -35.24M |
| June 30, 2016 | -47.89M |
| March 31, 2016 | -43.79M |
| December 31, 2015 | 265.68M |
| September 30, 2015 | -25.67M |
| June 30, 2015 | -32.64M |
| March 31, 2015 | -23.50M |
| December 31, 2014 | -4.492M |
| September 30, 2014 | -21.20M |
| June 30, 2014 | -19.67M |
| March 31, 2014 | -30.35M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 3.088B |
| ANI Pharmaceuticals, Inc. | 53.62M |
| Corcept Therapeutics, Inc. | 31.02M |
| Veru, Inc. | -5.467M |
| Johnson & Johnson | 7.295B |